November 20, 2015
MS Society of Canada funds new research to explore the role of the gut in pediatric MS
As few as five per cent of new cases of Multiple Sclerosis (MS) are...
As few as five per cent of new cases of Multiple Sclerosis (MS) are...
The number of people living with multiple sclerosis (MS) in British Columbia has increased...
Researchers hope the results of a new study will aid doctors in better supporting...
A new test developed by UBC researchers allows physicians to measure the effects of...
Every year, the UBC Hospital MS Clinic’s UBC MS Remyelinators get bigger and better. The...
UBC statistician John Petkau’s research seeks to improve the evaluation of multiple sclerosis (MS)...
Dr. Jacqueline Quandt is the Associate Director of the UBC MS Research Group at...
Collaborative International Research in Clinical and Longitudinal Experience for NMO Studies In North America,...
Interferon beta (IFN-β) is a disease-modifying drug used to reduce the risk of a...
The third annual Neuromyelitis Optica (NMO) Information Day will be held at the Djavad Mowafaghian Centre...
Molecular geneticist Dr. Carles Vilarino-Guell has played an important role in the identification of...
Amyotophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a devastating and...